Neuralstem Signs Research Agreement With University of Pennsylvania
Posted on: Wednesday, 19 December 2007, 03:00 CST
Neuralstem has entered into a clinical trial research agreement aimed at treating patients suffering from ischemic spastic paraplegia, a form of spinal cord paralysis, with the trustees of the University of Pennsylvania through its department of anesthesiology and critical care.
The institution's principal investigator is Albert Cheung, department of anesthesiology, Hospital of the University of Pennsylvania.
Ischemic spastic paraplegia is a painful form of extreme spasticity and rigidity that causes permanent and untreatable loss of motor function and paralysis.
Richard Garr, Neuralstem's president, said: "We are extremely pleased to be partnering with the University of Pennsylvania Hospital, and Dr Cheung's team on this important milestone. They bring world-class experience and talent across the many disciplines that are required for moving into the clinic for our first human trial."
Dr Cheung said: "We at Penn are deeply committed to finding a way to help these patients, and we are excited to be working with Neuralstem's cutting-edge technology."
Source: Datamonitor
Related Articles
- PASSHE to Implement Wimba Collaboration Suite in 14 Universities
- Verizon Wireless Expands Network in Lincoln University, Pennsylvania
- Lincoln University, Pennsylvania, Residents to Benefit From Verizon Wireless Network Expansion
- Energy Independence Strategy, Green Building Industry Share Common Goals, Says DEP Secretary
- Natural Resources Conservation Service Funds Innovative Project in Pennsylvania
- TU Team Takes Eighth in Auto Design Contest
- College Fair Invites Students With Disabilities
- Genshaft Details USF's Research Progress
- Environmental Education in Pennsylvania's Elementary Teacher Education Programs: A Statewide Report
- 11th Ams Education Symposium
 |
 |
User Comments (0)
RSS Feeds